Determination of celecoxib in human plasma by liquid chromatography-tandem mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jun 15:899:163-6. doi: 10.1016/j.jchromb.2012.05.013. Epub 2012 May 18.

Abstract

A liquid chromatography-electrospray tandem mass spectrometry method was developed and validated to quantitate celecoxib in human plasma. The assay was based on protein precipitation with methanol and liquid chromatography on a C₁₈ column (55 mm × 2 mm, 3 μm), the mobile phase consisted of methanol-10 mM ammonium acetate (75:25, v/v). Quantification was performed by mass spectrometry in the multiple reaction monitoring mode with negative electrospray ionization at m/z 380→316 and 384→320 for celecoxib and the internal standard celecoxib-D₄, respectively. The lower limit of quantitation was 7.0 ng/ml using 0.1 ml of plasma and linearity was demonstrated up to 1800 ng/ml. Intra-assay and inter-assay precision expressed by relative standard deviation was less than 4% and inaccuracy did not exceed 6% at all levels. The assay was applied to the analysis of samples from a pharmacokinetic study.

Publication types

  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Celecoxib
  • Chromatography, High Pressure Liquid / methods*
  • Cyclooxygenase 2 Inhibitors / blood*
  • Humans
  • Male
  • Middle Aged
  • Plasma / chemistry*
  • Pyrazoles / blood*
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Sulfonamides / blood*
  • Tandem Mass Spectrometry / methods*
  • Young Adult

Substances

  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib